{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:45:12Z","timestamp":1775666712132,"version":"3.50.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,12]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Remimazolam is a novel, ultrashort-acting benzodiazepine. This study aimed to compare the efficacy and safety of remimazolam and propofol for hysteroscopic examination, to determine the optimal dose of remimazolam combined with alfentanil for painless hysteroscopy, and to calculate its median effective dose (ED50).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Step 1: A total of 208 patients undergoing hysteroscopic examination were prospectively included in this study. Patients were randomized into 4 groups: 0.2\u2009mg\/kg remimazolam (group A), 0.25\u2009mg\/kg remimazolam besylate (group B), 0.3\u2009mg\/kg remimazolam (group C), and 2\u2009mg\/kg propofol (group D), with 52 patients in each group. One minute after losing consciousness, patients received an intravenous injection of alfentanil at 5 \u00b5g\/kg, followed by a continuous infusion of alfentanil at 0.5 \u00b5g\/kg\/min. If patients showed frowning, movement, or MOAA\/S\u2005&gt;\u20051, sedatives were added: 0.05\u2009mg\/kg\/dose of remimazolam for groups A, B, and C, and 0.5\u2009mg\/kg\/dose of propofol for group D. Step 2: Dixon\u2019s up-and-down method was used to calculate the ED50 of remimazolam combined with alfentanil during hysteroscopic examination.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Main results:<\/jats:title>\n            <jats:p>The sedation success rates of the remimazolam groups were 88.46%, 94.23%, and 98.08%, respectively, compared to 96.15% in the propofol group, with no significant difference (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.175). MAP in groups A and B was higher than in group D (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05), and significantly higher in group C than in group D (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.0016). SpO2 values in groups A, B, and C were higher than in group D at T2 to T3 (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001). HR in groups A, B, and C was significantly higher than in group D (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001). The ED50 of remimazolam combined with alfentanil in hysteroscopy was 0.244\u2009mg\/kg, 95%CI (0.195\u20130.22) and ED95 was 0.282\u2009mg\/kg, 95%CI (0.261\u20131.619).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>In hysteroscopy, the sedative effect of remimazolam is like that of propofol, with 0.25\u2009mg\/kg remimazolam showing better safety and efficacy, and less impact on the respiratory and circulatory systems. Additionally, under the influence of alfentanil, the ED50 of remimazolam in hysteroscopy is 0.244\u2009mg\/kg, with no severe adverse reactions observed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000037627","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T19:03:46Z","timestamp":1712948626000},"page":"e37627","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Effectiveness and safety of remimazolam combined with alfentanil in hysteroscopic examination: A prospective, randomized, single-blind trial"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0051-1559","authenticated-orcid":false,"given":"Bei","family":"Huang","sequence":"first","affiliation":[{"name":"The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China"},{"name":"The Affiliated Nanhua Hospital, Department of Anesthesiology, Hengyang Medical School, University of Suth China, Hengyang, Hunan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan-Ping","family":"Li","sequence":"additional","affiliation":[{"name":"The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China"},{"name":"The Affiliated Nanhua Hospital, Department of Anesthesiology, Hengyang Medical School, University of Suth China, Hengyang, Hunan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang-Kai","family":"Tan","sequence":"additional","affiliation":[{"name":"The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China"},{"name":"The Affiliated Nanhua Hospital, Department of Anesthesiology, Hengyang Medical School, University of Suth China, Hengyang, Hunan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9218-2653","authenticated-orcid":false,"given":"Na","family":"Liang","sequence":"additional","affiliation":[{"name":"The Affiliated Nanhua Hospital, Department of Anesthesiology, Hengyang Medical School, University of Suth China, Hengyang, Hunan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250618","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41556-019-0360-z","article-title":"Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening.","volume":"21","author":"Boretto","year":"2019","journal-title":"Nat Cell Biol"},{"key":"R2-20250618","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s13304-020-00713-w","article-title":"Updates in office hysteroscopy: a practical decalogue to perform a correct procedure.","volume":"72","author":"Vitale","year":"2020","journal-title":"Updates Surg"},{"key":"R3-20250618","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1080\/01443615.2021.1971176","article-title":"Outcomes of surgical hysteroscopy: 25 years of observational study.","volume":"42","author":"Vil\u00e0 Famada","year":"2022","journal-title":"J Obstet Gynaecol"},{"key":"R4-20250618","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00001703-199206000-00015","article-title":"Hysteroscopic surgery.","volume":"4","author":"Donnez","year":"1992","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R5-20250618","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/IJWH.S98579","article-title":"Management of abnormal uterine bleeding\u2014focus on ambulatory hysteroscopy.","volume":"10","author":"Kolhe","year":"2018","journal-title":"Int J Womens Health"},{"key":"R6-20250618","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.joms.2020.05.015","article-title":"Dexmedetomidine provides fewer respiratory events compared with propofol and fentanyl during third molar surgery: a randomized clinical trial.","volume":"78","author":"Nolan","year":"2020","journal-title":"J Oral Maxillofac Surg"},{"key":"R7-20250618","doi-asserted-by":"crossref","first-page":"223","DOI":"10.23736\/S0375-9393.21.15917-6","article-title":"Gastroscopy sedation: clinical trial comparing propofol and sufentanil with or without remimazolam.","volume":"88","author":"Xiao","year":"2022","journal-title":"Minerva Anestesiol"},{"key":"R8-20250618","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/s12876-022-02467-8","article-title":"Efficacy and safety of subanesthetic doses of esketamine combined with propofol in painless gastrointestinal endoscopy: a prospective, double-blind, randomized controlled trial.","volume":"22","author":"Zhan","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"R9-20250618","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/bcp.15072","article-title":"The median effective concentration of propofol with different doses of esketamine during gastrointestinal endoscopy in elderly patients: a randomized controlled trial.","volume":"88","author":"Yang","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"R10-20250618","doi-asserted-by":"crossref","first-page":"e23317","DOI":"10.1097\/MD.0000000000023317","article-title":"Comparison of dexmedetomidine-propofol and ketamine-propofol administration during sedation-guided upper gastrointestinal system endoscopy.","volume":"99","author":"Tekeli","year":"2020","journal-title":"Medicine (Baltim)"},{"key":"R11-20250618","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17085\/apm.21115","article-title":"Remimazolam: pharmacological characteristics and clinical applications in anesthesiology.","volume":"17","author":"Kim","year":"2022","journal-title":"Anesth Pain Med (Seoul)"},{"key":"R12-20250618","first-page":"929","article-title":"Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and\/or anesthesia in day-case surgical and non-surgical procedures.","volume":"13","author":"Rogers","year":"2010","journal-title":"IDrugs"},{"key":"R13-20250618","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/jcpt.13525","article-title":"Efficacy and safety of remimazolam tosylate in hysteroscopy: a randomized, single-blind, parallel controlled trial.","volume":"47","author":"Zhang","year":"2022","journal-title":"J Clin Pharm Ther"},{"key":"R14-20250618","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12871-022-01805-3","article-title":"Sedative effect of remimazolam combined with alfentanil in colonoscopic polypectomy: a prospective, randomized, controlled clinical trial.","volume":"22","author":"Xin","year":"2022","journal-title":"BMC Anesthesiol"},{"key":"R15-20250618","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12871-021-01390-x","article-title":"Correction to: Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial.","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Anesthesiol"},{"key":"R16-20250618","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.gie.2015.08.062","article-title":"A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy.","volume":"83","author":"Pambianco","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"R17-20250618","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00540-020-02788-6","article-title":"Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial.","volume":"34","author":"Doi","year":"2020","journal-title":"J Anesth"},{"issue":"5S Suppl 2","key":"R18-20250618","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1097\/SAP.0000000000003377","article-title":"Use of remimazolam combined with alfentanil for plastic surgery anesthesia cases: a clinical trial.","volume":"90","author":"Xu","year":"2023","journal-title":"Ann Plast Surg"},{"key":"R19-20250618","first-page":"244","article-title":"Validity and reliability of the observer\u2019s assessment of alertness\/sedation scale: study with intravenous midazolam.","volume":"10","author":"Chernik","year":"1990","journal-title":"J Clin Psychopharmacol"},{"key":"R20-20250618","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/EJA.0b013e328318c666","article-title":"Comparison of etomidate-remifentanil and propofol-remifentanil sedation in patients scheduled for colonoscopy.","volume":"26","author":"Toklu","year":"2009","journal-title":"Eur J Anaesthesiol"},{"key":"R21-20250618","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00540-021-02930-y","article-title":"A mechanism of re-sedation caused by remimazolam.","volume":"35","author":"Yamamoto","year":"2021","journal-title":"J Anesth"},{"key":"R22-20250618","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.2147\/DDDT.S339535","article-title":"The efficacy and safety of remimazolam tosilate versus etomidate-propofol in elderly outpatients undergoing colonoscopy: a prospective, randomized, single-blind, non-inferiority trial.","volume":"15","author":"Liu","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"R23-20250618","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/ALN.0000000000003103","article-title":"Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. Pharmacokinetics and Clinical Pharmacodynamics.","volume":"132","author":"Sch\u00fcttler","year":"2020","journal-title":"Anesthesiology"},{"key":"R24-20250618","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/01.anes.0000267503.85085.c0","article-title":"CNS 7056: a novel ultra-short-acting Benzodiazepine.","volume":"107","author":"Kilpatrick","year":"2007","journal-title":"Anesthesiology"},{"key":"R25-20250618","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00228-019-02800-3","article-title":"Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers.","volume":"76","author":"Sheng","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"R26-20250618","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1213\/ANE.0b013e3182a705ae","article-title":"A phase Ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopy.","volume":"117","author":"Worthington","year":"2013","journal-title":"Anesth Analg"},{"key":"R27-20250618","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.clinthera.2020.02.006","article-title":"Psychomotor recovery following remimazolam-induced sedation and the effectiveness of flumazenil as an antidote.","volume":"42","author":"Chen","year":"2020","journal-title":"Clin Ther"},{"key":"R28-20250618","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/jgh.15188","article-title":"Remimazolam tosilate in upper gastrointestinal endoscopy: a multicenter, randomized, non-inferiority, phase III trial.","volume":"36","author":"Chen","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"R29-20250618","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.chest.2018.09.015","article-title":"Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy.","volume":"155","author":"Pastis","year":"2019","journal-title":"Chest"},{"key":"R30-20250618","doi-asserted-by":"crossref","first-page":"173639","DOI":"10.1016\/j.ejphar.2020.173639","article-title":"Impact of concurrent remifentanil on the sedative effects of remimazolam, midazolam and propofol in cynomolgus monkeys.","volume":"890","author":"Kops","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"R31-20250618","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/ACO.0000000000000877","article-title":"Remimazolam for anaesthesia or sedation.","volume":"33","author":"Sneyd","year":"2020","journal-title":"Curr Opin Anaesthesiol"},{"key":"R32-20250618","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1213\/ANE.0000000000002022","article-title":"Inhaled remimazolam potentiates inhaled remifentanil in rodents.","volume":"124","author":"Bevans","year":"2017","journal-title":"Anesth Analg"},{"key":"R33-20250618","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2515\/therapie:2005007","article-title":"Benzodiazepine and hiccup: three case reports.","volume":"60","author":"Micallef","year":"2005","journal-title":"Therapie"},{"key":"R34-20250618","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2147\/DDDT.S408584","article-title":"Feasibility and safety of remazolam versus propofol when inserting laryngeal masks without muscle relaxants during hysteroscopy.","volume":"17","author":"Tang","year":"2023","journal-title":"Drug Des Devel Ther"},{"key":"R35-20250618","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1572-0241.2005.41065.x","article-title":"Gastroesophageal reflux disease in a low-income region in Turkey.","volume":"100","author":"Bor","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R36-20250618","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.arbres.2011.11.005","article-title":"Hiccups induced by midazolam during sedation in flexible bronchoscopy.","volume":"48","author":"Arroyo-C\u00f3zar","year":"2012","journal-title":"Arch Bronconeumol"},{"key":"R37-20250618","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.2147\/DDDT.S382412","article-title":"ED50 and ED95 of propofol combined with different doses of intravenous lidocaine for first-trimester uterine aspiration: a prospective dose-finding study using up-and-down sequential allocation method.","volume":"16","author":"Zhang","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"R38-20250618","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/bcpt.13280","article-title":"ED50 of propofol in combination with low-dose sufentanil for intravenous anaesthesia in hysteroscopy.","volume":"125","author":"Yu","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R39-20250618","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/s12871-022-01914-z","article-title":"Determining the effective dose of esketamine for mitigating pain during propofol injection by Dixon\u2019s up-and-down method: a double-blind, prospective clinical study of drug dose response.","volume":"22","author":"Tan","year":"2022","journal-title":"BMC Anesthesiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037627","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T16:02:12Z","timestamp":1750262532000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,12]]},"references-count":39,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037627","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,12]]}}}